Voltar
Artigo Revisado por pares
BIBTEX RIS

Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study

2012; Springer Science+Business Media; Volume: 134; Issue: 1 Linguagem: Inglês

10.1007/s10549-012-2045-1

ISSN

1573-7217

Autores

Marta Pestrin, Silvia Bessi, Fabio Puglisi, Alessandro Marco Minisini, Giovanna Masci, Nicola Battelli, Alberto Ravaioli, Luca Gianni, R. Di Marsico, Carlo Tondini, Stefania Gori, R. Charles Coombes, Justin Stebbing, Laura Biganzoli, Marc Buyse, Angelo Di Leo,

Tópico(s)

Advanced Breast Cancer Therapies

Referência(s)